Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Bullboard Posts
Post by senatoriceon Jan 10, 2011 8:44am
211 Views
Post# 17947112

About SBM

About SBM

About Us

Launched in 2008, Sirona Biochem specializes in carbohydrate-based chemistry.  Using a proprietary chemistry technique, we aim to improve the properties of carbohydrate-based drugs to make them more commercially viable. 

Sirona Biochem has developed a chemistry technique that we believe can enhance carbohydrate-based molecules.  Carbohydrate-based molecules offer immense potential for the development of therapeutics, cosmeceuticals and biological ingredients.  But these types of molecules are finicky and usually unstable as they tend to break down, making them challenging to produce.  Sirona Biochem uses a proprietary fluorination process to enhance the properties of these molecules. 

We believe our chemistry method can be applied to drugs in development to improve their properties, discontinued drugs that may have been shelved for stability reasons, or for the development of new products for cosmetics and biological manufacturing.  Using our proprietary chemistry process, we feel we can maximize the commercial value of carbohydrate-based molecules.

Sirona Biochem is applying its chemistry expertise towards the development of diabetes and obesity therapeutics, anti-aging cosmetic ingredients and biological ingredients.

Bullboard Posts